BAx BAX バクスタ― インタ―ナショナル

 BAXのチャート


 BAXの企業情報

symbol BAx
会社名 Baxter International Inc (BAX バクスタ― インタ―ナショナル)
分野(sector)   
産業(industry)   
業種 医療機器_医療用品_ディストリビュ―タ―   医療関連(Health Care)
概要 事業概要 バクスター・インターナショナル(Baxter International Inc.)は子会社を通じて腎臓及び病院用製品を提供する。同社は2つの事業区分を運営する。病院製品事業は、滅菌静脈内(IV)溶液および投与セット、予混合薬剤および薬剤再構成システム、注射剤、IV栄養製品、非経口栄養療法、輸液ポンプ、吸入麻酔薬およびバイオ手術用製品のための充填済みバイアルおよびシリンジを製造する。レナール事業は、末期腎疾患、または腎臓疾患および急性腎障害の患者のニーズに応じて、腹膜透析(PD)、血液透析(HD)、継続的腎代替療法(CRRT)および追加の透析サービス等のポートフォリオを提供する。同社の製品は、病院、腎臓透析センター、老人ホーム、リハビリテーションセンター、医院、および医師の監督の下で自宅にいる患者によって使用されている。  バクスタ―・インタ―ナショナルは米国の医療機器・医薬品メ―カ―。事業は2部門で構成。バイオサイエンス部門は血友病治療用血漿タンパク製剤などの生物薬剤製品のほか、免疫不全症や止血用の生物学的組織接着剤などの製造を行う。医療製品部門は静脈内投与用の注射器などを製造、腹膜透析用減菌透析液、院内用血液透析装置も扱う。本社はイリノイ州。  Baxter International, Inc. provides portfolio of essential renal and hospital products, including acute and chronic dialysis, sterile IV solutions, infusion systems and devices, parenteral nutrition therapies; premixed and oncolytic injectable, bio surgery products and anesthetics, drug reconstitution systems and pharmacy automation, software and services. It operates through the following segment: Americas, Europe, Middle East & Africa and Asia-Pacific. The company was founded by Davis Baxter in 1931 and is headquartered in Deerfield, IL.
本社所在地 One Baxter Parkway Deerfield IL 60015 USA
代表者氏名 Jose E. Almeida
代表者役職名 Chairman of the Board President Chief Executive Officer
電話番号 +1 847-948-2000
設立年月日 11597
市場名 NYSE(ニューヨーク証券取引所)
ipoyear
従業員数 50000人
url www.baxter.com
nasdaq_url
adr_tso
EBITDA EBITDA(百万ドル) 2545.00000
終値(lastsale)
時価総額(marketcap)
時価総額 時価総額(百万ドル) 41558.95000
売上高 売上高(百万ドル) 11127.00000
企業価値(EV) 企業価値(EV)(百万ドル) 43202.95000
当期純利益 当期純利益(百万ドル) 1423.00000
決算概要 決算概要 BRIEF: For the fiscal year ended 31 December 2018 Baxter International Inc revenues increased 5% to $11.13B. Net income before extraordinary items increased 9% to $1.42B. Revenues reflect Americas segment increase of 4% to $5.96B EMEA segment increase of 8% to $2.96B APAC segment increase of 5% to $2.21B United States segment increase of 32% to $5.96B Asia pacific segment increase of 5% to $2.21B.

 BAXのテクニカル分析


 BAXのニュース

   Baxter Supports New Study Showing Nutritional Needs in Critically Ill COVID-19 Patients and Published Practical Guidelines for Care  2020/10/14 12:00:00 Business Wire
DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global leader in nutrition therapy, supports interim findings of an ongoing prospective study, “Persistent Hypermetabolism and Longitudinal Energy Expenditure in Critically Ill Patients with COVID-19 (LEEP-COVID),” demonstrating the role of indirect calorimetry (IC) in improving the accuracy of measuring COVID-19 patients’ nutritional needs during their intensive care unit (ICU) stay. The study, supported by Baxter throug
   Stem Cell Repair Market 2020-2028 advance research can be used for heart repairing with top key players Medtronic, Boston Scientific, Abbott, AxoGen, Baxter International, LivaNova  2020/10/14 11:06:08 OpenPR
A special process helps isolate the needed cells by using a centrifuge. Those cells are then delivered to the area of injury such as an arthritic knee through ultrasound guidance. The stem cells activate to create healthy new tissue to
   Home Infusion Therapy Devices Market to Witness Robust Expansion by 2026 with Top Key players like Baxter International Inc., CareFusion, Smiths Medical, ICU Medical, Terumo BCT  2020/10/13 13:42:36 OpenPR
Infusion therapy has become a popular pain relieve treatment method, especially for diseases where oral medication is least effective. In cases of gastrointestinal diseases, diabetes and cancer-related pain infusion therapy is common. Moreover, infusion therapy is equally effective in
   Clinical Decision Support Systems Market: How the Business Will Grow in 2027? Prominent Players: Baxter International Inc., BD, PeraHealth, Epic Systems Corporation  2020/10/12 11:30:13 OpenPR
The clinical decision support systems market accounted to US$ 2,772.60 Mn in 2018 and is expected to grow at a CAGR of 9.2% during the forecast period 2019 – 2027, to account for US$ 5,983.38 Mn by 2027. This research report
   Inhalation Anesthesia Market is Generating Revenue of $1.54 Billion by 2026 | AbbVie Inc., Baxter International Inc  2020/10/08 12:24:07 OpenPR
According to the research report published by Allied Market Research, the global inhalation anesthesia market is expected to register a CAGR of 4.2% from 2019 to 2026. The research includes changing market dynamics, top impacting factors, key investment pockets, value
   Analysis on Impact of COVID-19- Global Von Willebrand Disease Therapeutics Market 2020-2024 | Evolving Opportunities with Apotex Inc. and Baxter International Inc. | Technavio  2020/09/07 19:30:00 Business Wire
LONDON--(BUSINESS WIRE)-- #GlobalVonWillebrandDiseaseTherapeuticsMarket--The Global Von Willebrand Disease Therapeutics Market will grow by $ 165.48 mn during 2020-2024
   P/E Ratio Insights for Baxter International  2020/09/04 11:26:00 Benzinga
Right now, Baxter International Inc. (NYSE: BAX) share price is at $81.97, after a 1.87% decrease. Over the past month, the stock …
   Baxter Announces U.S. FDA De Novo Authorization for Theranova Dialyzers Enabling HDx Therapy  2020/08/31 11:30:00 Business Wire
DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global innovator in renal care, today announced the U.S. Food and Drug Administration (FDA) has granted the De Novo application for Theranova, the company’s novel dialysis membrane. Theranova was designed to deliver expanded hemodialysis (HDx) therapy, which filters a wider range of molecules from the blood than traditional hemodialysis (HD) filters, like high-flux membranes, by targeting effective removal of conventional
   Global Topical Absorbable Hemostats Market 2015-2030 (COVID-19's Impact) Featuring Ethicon, C. R. Bard, Baxter International, Pfizer, Braun Melsungen and Teleflex - ResearchAndMarkets.com  2020/08/26 09:49:00 Business Wire
DUBLIN--(BUSINESS WIRE)--The "Topical Absorbable Hemostats (Wound Care Management) - Global Market Analysis and Forecast Model (COVID-19 market impact)" report has been added to ResearchAndMarkets.com's offering. This market model discusses in detail the impact of COVID-19 on Topical Absorbable Hemostats market for the year 2020 and beyond. Each of the covered 39 country's color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. To inc
   Baxter International : to Present at the Morgan Stanley Virtual 18th Annual Global Healthcare Conference | MarketScreener  2020/08/20 20:28:03 MarketScreener
PDF DEERFIELD, Ill. - August 20, 2020 Baxter International Inc. , a leading global medical products company, will present at the virtual… | August 20, 2020
   Analysis on Impact of COVID-19- Global Von Willebrand Disease Therapeutics Market 2020-2024 | Evolving Opportunities with Apotex Inc. and Baxter International Inc. | Technavio  2020/09/07 19:30:00 Business Wire
LONDON--(BUSINESS WIRE)-- #GlobalVonWillebrandDiseaseTherapeuticsMarket--The Global Von Willebrand Disease Therapeutics Market will grow by $ 165.48 mn during 2020-2024
   P/E Ratio Insights for Baxter International  2020/09/04 11:26:00 Benzinga
Right now, Baxter International Inc. (NYSE: BAX) share price is at $81.97, after a 1.87% decrease. Over the past month, the stock …
   Baxter Announces U.S. FDA De Novo Authorization for Theranova Dialyzers Enabling HDx Therapy  2020/08/31 11:30:00 Business Wire
DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global innovator in renal care, today announced the U.S. Food and Drug Administration (FDA) has granted the De Novo application for Theranova, the company’s novel dialysis membrane. Theranova was designed to deliver expanded hemodialysis (HDx) therapy, which filters a wider range of molecules from the blood than traditional hemodialysis (HD) filters, like high-flux membranes, by targeting effective removal of conventional
   Global Topical Absorbable Hemostats Market 2015-2030 (COVID-19's Impact) Featuring Ethicon, C. R. Bard, Baxter International, Pfizer, Braun Melsungen and Teleflex - ResearchAndMarkets.com  2020/08/26 09:49:00 Business Wire
DUBLIN--(BUSINESS WIRE)--The "Topical Absorbable Hemostats (Wound Care Management) - Global Market Analysis and Forecast Model (COVID-19 market impact)" report has been added to ResearchAndMarkets.com's offering. This market model discusses in detail the impact of COVID-19 on Topical Absorbable Hemostats market for the year 2020 and beyond. Each of the covered 39 country's color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. To inc
   Baxter International : to Present at the Morgan Stanley Virtual 18th Annual Global Healthcare Conference | MarketScreener  2020/08/20 20:28:03 MarketScreener
PDF DEERFIELD, Ill. - August 20, 2020 Baxter International Inc. , a leading global medical products company, will present at the virtual… | August 20, 2020

 関連キーワード  (医療機器_医療用品_ディストリビュ―タ― 米国株 BAX バクスタ― インタ―ナショナル BAX )

医療で使われる機器のこと。レントゲン装置やからだの断面を画像化できるMRI(磁気共鳴画像)装置など高機能機器を含め数多くの種類がある。医療現場で使われるため、正確で精密である点などが求められる。医療機器への需要は着実に高まっており、電機メーカーなどからの進出も進んでいる。

 twitter  (公式ツイッターやCEOツイッターなど)